Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Histone deacetylases (HDACs) mediate changes in nucleosome conformation and are important in the regulation of gene expression. HDACs are involved in cell-cycle progression and differentiation, and their deregulation is associated with several cancers. HDAC inhibitors, such as trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA), have anti-tumour effects, as they can inhibit cell growth, induce terminal differentiation and prevent the formation of tumours in mice models, and they are effective in the treatment of promyelocytic leukemia. Here we describe the structure of the histone deacetylase catalytic core, as revealed by the crystal structure of a homologue from the hyperthermophilic bacterium Aquifex aeolicus, that shares 35.2% identity with human HDAC1 over 375 residues, deacetylates histones in vitro and is inhibited by TSA and SAHA. The deacetylase, deacetylase-TSA and deacetylase-SAHA structures reveal an active site consisting of a tubular pocket, a zinc-binding site and two Asp-His charge-relay systems, and establish the mechanism of HDAC inhibition. The residues that make up the active site and contact the inhibitors are conserved across the HDAC family. These structures also suggest a mechanism for the deacetylation reaction and provide a framework for the further development of HDAC inhibitors as antitumour agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conformation of this loop is virtually identical in the three HDLP structures (Finnin et al., 1999), suggesting that the surface of HDLP is less malleable than that of HDAC8 around the binding site pocket.”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Finnin et al., 1999
In the citing paper
“The apparent reduced flexibility in the HDLP surface may also explain why it is less efficient in histone deacetylase assays (Finnin et al., 1999).”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Finnin et al., 1999
In the citing paper
“Finnin et al. (1999) have suggested that H143 protonates the lysine after the carbon-nitrogen scissile bond breaks.”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Finnin et al., 1999
In the citing paper
“HDAC6 also contributes to mitochondrial trafficking and misfolded protein clearance (Perry et al., 2017; Finnin et al., 1999), highlighting the HDAC6–microtubule–mitochondria axis as an important regulatory node beyond chromatin-dependent mechanisms.”
From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Finnin et al., 1999
In the citing paper
“HDAC6 also contributes to mitochondrial trafficking and misfolded protein clearance (Perry et al., 2017; Finnin et al., 1999), highlighting the HDAC6–microtubule–mitochondria axis as an important regulatory node beyond chromatin-dependent mechanisms.”
From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Finnin et al., 1999
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
[26] Raster3D: Photorealistic molecular graphics
Merritt, E. A., & Bacon, D. J. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)77028-9 · Cited by 3,739
The relation between the divergence of sequence and structure in proteins.
Chothia, C., & Lesk, A. M. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04288.x · Cited by 2,458
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815
The complete genome of the hyperthermophilic bacterium Aquifex aeolicus
Deckert, G., Warren, P. V., Gaasterland, T., Young, W. G., Lenox, A. L., Graham, D. E., Overbeek, R., Snead, M. A., Keller, M., Aujay, M., et al. (1998) · Nature · doi:10.1038/32831 · Cited by 1,097
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914
Self-citation
Research works printed but not linked: 2
- Cohen,L. A. et al. Inhibition of N-methylnitrosourea-induced tumours by the cytodifferentiating agent, suberanilohydroxamic acid (SAHA). Proc. AACR 39, 108, abstr. 736 (1998).
- Desai,D., El-Bayoumy,K. & Amin,S. Chemopreventive efficacy of suberanilohydroxamic acid (SAHA), a cytodifferentiating agent, against tobacco-specific nitrosamine 4-(methylinitros-amino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in female A/J mice. Proc. AACR 40, 2396, abstr. 362 (1999).
Cited by
Items 801–900 of 1,007
Design and synthesis of novel isoxazole-based HDAC inhibitors
Conti, P., Tamborini, L., Pinto, A., Solá, L., Ettari, R., Mercurio, C., & Micheli, C. D. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.06.035 · Cited by 36
Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors
Anandan, S., Ward, J. S., Brokx, R. D., Denny, T. A., Bray, M. R., Patel, D. V., & Xiao, X.-Y. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.07.050 · Cited by 36
Haakenson, J., & Zhang, X. M. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14059514 · Cited by 36
Histone modifications, DNA methylation, and the epigenetic code of alcohol use disorder
Bohnsack, J. P., & Pandey, S. C. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.08.005 · Cited by 36
The Chemistry of Marine Sponges∗
Ebada, S. S., & Proksch, P. (2012) · Springer eBooks · doi:10.1007/978-90-481-3834-0_4 · Cited by 36
Ward, C. S., Eriksson, P., Izquierdo-García, J. L., Brandes, A., & Ronen, S. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062610 · Cited by 36
Histone deacetylases in control of skeletogenesis
Westendorf, J. J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21486 · Cited by 36
Histone deacetylase inhibitors induce antigen specific anergy in lymphocytes: A comparative study
Edens, R. E., Dagtas, A. S., & Gilbert, K. M. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.07.001 · Cited by 36
Zhao, W.-N., Ghosh, B., Tyler, M., Lalonde, J., Joseph, N. F., Kosaric, N., Fass, D. M., Tsai, L.-H., Mazitschek, R., & Haggarty, S. J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00116 · Cited by 35
Histone acetylation and deacetylation – Mechanistic insights from structural biology
Patel, A. B., He, Y., & Radhakrishnan, I. (2023) · Gene · doi:10.1016/j.gene.2023.147798 · Cited by 35
Induction of GRP78 by valproic acid is dependent upon histone deacetylase inhibition
Shi, Y., Gerritsma, D. A., Bowes, A. J., Capretta, A. A., & Werstuck, G. H. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.06.006 · Cited by 35
In Silico and in Vitro Interactions between Short Chain Fatty Acids and Human Histone Deacetylases
Ho, R. H., Chan, J. C. Y., Fan, H., Kioh, D. Y. Q., Lee, B. W., & Chan, E. C. Y. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00508 · Cited by 35
Li, M., Liu, D., Lee, D., Kapoor, S., Gibson-Corley, K. N., Quinn, T. P., Sagastume, E. A., Mott, S. L., Walsh, S. A., Acevedo, M. R., et al. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00512 · Cited by 35
Natural Products as Zinc‐Dependent Histone Deacetylase Inhibitors
Tan, S., & Liu, Z. (2015) · ChemMedChem · doi:10.1002/cmdc.201402460 · Cited by 35
Small-Molecule Chromatin-Modifying Agents: Therapeutic Applications
Mai, A. (2010) · Epigenomics · doi:10.2217/epi.10.7 · Cited by 35
Varricchio, L., Dell’Aversana, C., Nebbioso, A., Migliaccio, G., Altucci, L., Mai, A., Grazzini, G., Bieker, J. J., & Migliaccio, A. R. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.02.019 · Cited by 35
Ghith, A., Ismail, N. S. M., Youssef, K. M., & Abouzid, K. A. M. (2017) · Archiv der Pharmazie · doi:10.1002/ardp.201700242 · Cited by 35
Antiproliferative and Phenotype-Transforming Antitumor Agents Derived from Cysteine
Glenn, M. P., Kahnberg, P., Boyle, G. M., Hansford, K. A., Hans, D., Martyn, A. C., Parsons, P. G., & Fairlie, D. P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030222i · Cited by 35
Price, S., Bordogna, W., Braganza, R., Bull, R. J., Dyke, H. J., Gardan, S., Gill, M., Harris, N. V., Heald, R. A., van den Heuvel, M., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.10.045 · Cited by 35
Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitors
Su, H. L., Altucci, L., & You, Q. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2289 · Cited by 34
Mah, L.-J., Orlowski, C., Ververis, K., Vasireddy, R. S., El‐Osta, A., & Karagiannis, T. C. (2011) · Genome Integrity · doi:10.1186/2041-9414-2-3 · Cited by 34
Sun, N., Yang, K., Yan, W., Yao, M., Yu, C., Duan, W., Gu, X., Guo, D. M., Jiang, H., Xie, C., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01985 · Cited by 34
Backe, M. B., Andersson, J., Bacos, K., Christensen, D. P., Hansen, J. B., Dorosz, J., Gajhede, M., Dahlby, T., Bysani, M., Kristensen, L. H., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.07.001 · Cited by 34
Subramanian, K., Rauniyar, N., Lavallée‐Adam, M., Yates, J. R., & Balch, W. E. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.064949 · Cited by 34
Nishino, N., Yoshikawa, D., Watanabe, L. A., Kato, T., Jose, B., Komatsu, Y., Sumida, Y., & Yoshida, M. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.018 · Cited by 34
Alenad, A. M., Al‐Jaber, N. A., Krishnaswamy, S., Yakout, S. M., Al‐Daghri, N. M., & Alokail, M. S. (2013) · Journal of Medicinal Plants Research · doi:10.5897/jmpr.9000036 · Cited by 34
Mayr, C., Kiesslich, T., Erber, S., Bekric, D., Dobias, H., Beyreis, M., Ritter, M., Jäger, T., Neumayer, B., Winkelmann, P., et al. (2021) · Cancers · doi:10.3390/cancers13153862 · Cited by 34
Verma, M., Dunn, B. K., Ross, S. A., JAIN, P., Wang, W., Hayes, R. B., & Umar, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05984.x · Cited by 34
Long, J., Zhao, J., Yan, Z., Liu, Z., & Wang, N. (2008) · International Journal of Cancer · doi:10.1002/ijc.24074 · Cited by 34
Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer
Luu, T. H., Kim, K., Blanchard, S., Anyang, B. N., Hurria, A., Yang, L., Beumer, J. H., Somlo, G., & Yen, Y. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4516-x · Cited by 34
Vorinostat and Belinostat, hydroxamate-based anti-cancer agents, are nitric oxide donors
Kenny, R. G., Ude, Ž., Docherty, J. R., & Marmion, C. J. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110981 · Cited by 34
Liu, X., Song, H. Y., Zhang, J. X., Han, B. C., Wei, X., H., X., Cui, W. K., & Chen, Y. (2010) · Molecular Informatics · doi:10.1002/minf.200900014 · Cited by 34
Msx3 protein recruits histone deacetylase to down-regulate the Msx1 promoter
Mehra‐Chaudhary, R., MATSUI, H., & Raghow, R. (2000) · Biochemical Journal · doi:10.1042/bj3530013 · Cited by 33
Choi, S. E., Weerasinghe, S. V. W., & Pflum, M. K. H. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.08.027 · Cited by 33
Amide analogues of TSA: synthesis, binding mode analysis and HDAC inhibition
Ommeslaeghe, K. V., Elaut, G., Brecx, V., Papeleu, P., Iterbeke, K., Geerlings, P., Tourwé, D., & Rogiers, V. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00284-1 · Cited by 33
Structural Biology of Human Metal-Dependent Histone Deacetylases
Schapira, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_10 · Cited by 33
Ilies, M., Dowling, D., Lombardi, P. M., & Christianson, D. W. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.07.100 · Cited by 33
Kia, A., Yata, T., Hajji, N., & Hajitou, A. (2013) · Viruses · doi:10.3390/v5102561 · Cited by 33
Discovery of a new class of histone deacetylase inhibitors with a novel zinc binding group
Li, Y., & Woster, P. M. (2015) · MedChemComm · doi:10.1039/c4md00401a · Cited by 33
Guandalini, L., Cellai, C., Laurenzana, A., Scapecchi, S., Paoletti, F., & Romanelli, M. N. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.119 · Cited by 33
Discovery and Mechanism of Natural Products as Modulators of Histone Acetylation
Salvador, L. A., & Luesch, H. (2012) · Current Drug Targets · doi:10.2174/138945012802008973 · Cited by 33
Histone deacetylase in neuropathology
Gupta, R. V., Ambasta, R. K., & Kumar, P. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2020.09.004 · Cited by 33
Wan, G., Feng, Z., Zhang, Q., Li, X., Ran, K., Feng, H., Luo, T.-W., Zhou, S., Su, C., Wei, W., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01413 · Cited by 33
Novel molecular targeted therapies for refractory thyroid cancer
Perez, C. A., Santos, E. S., Arango, B. A., Raez, L. E., & Cohen, E. E. W. (2011) · Head & Neck · doi:10.1002/hed.21755 · Cited by 33
Sardiu, M. E., Smith, K. T., Groppe, B. D., Gilmore, J. M., Saraf, A., Egidy, R., Peak, A., Seidel, C. W., Florens, L. A., Workman, J. L., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.037127 · Cited by 33
Natural products development under epigenetic modulation in fungi
Li, C., Chung, Y., Wu, Y., Hunyadi, A., Wang, C. C. C., & Chang, F. (2020) · Phytochemistry Reviews · doi:10.1007/s11101-020-09684-7 · Cited by 33
Mohan, R., Sharma, A. K., Gupta, S., & Ramaa, C. S. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9623-3 · Cited by 33
Hosoya, T., Hirokawa, T., Takagi, M., & Shin‐ya, K. (2012) · Journal of Natural Products · doi:10.1021/np200843k · Cited by 33
Lee, H., Yu, X., Bang, J., Cho, S. J., Deb, G. K., Kim, B., & Kong, I. (2010) · Theriogenology · doi:10.1016/j.theriogenology.2010.06.016 · Cited by 33
Influence of Stacking on the Hydrogen Bond Donating Potential of Nucleic Bases
Vanommeslaeghe, K., Mignon, P., Loverix, S., Tourwé, D., & Geerlings, P. (2006) · Journal of Chemical Theory and Computation · doi:10.1021/ct600150n · Cited by 33
Choi, S. E., & Pflum, M. K. H. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.093 · Cited by 32
Sulfamides as novel histone deacetylase inhibitors
Wahhab, A., Smil, D. V., Ajamian, A., Allan, M., Chantigny, Y., Therrien, É., Nguyen, N. N. M., Manku, S., Leit, S. M., Rahil, J. F., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.11.081 · Cited by 32
Hanessian, S., Vinci, V., Auzzas, L., Marzi, M., & Giannini, G. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.06.090 · Cited by 32
Zhang, S., Zhan, L., Li, X., Yang, Z., Luo, Y., & Zhao, H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.62001 · Cited by 32
gp-91 mediates histone deacetylase inhibition-induced cardioprotection
Zhao, T. C., Zhang, L. X., Cheng, G., & Liu, J. T. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.04.007 · Cited by 32
Dietary Manipulation of Histone Structure and Function
Ho, E., & Dashwood, R. H. (2010) · Lifestyle Genomics · doi:10.1159/000324359 · Cited by 32
Huong, T. L., Dung, D. T. M., Huan, N.-V., Cuong, L.-V., Pham‐The, H., Le‐Thi‐Thu, H., Kim, J., Kim, Y.-G., Han, S., & Nam, N. (2017) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2017.02.002 · Cited by 32
Drug Discovery for Histone Deacetylase Inhibition: Past, Present and Future of Zinc-Binding Groups
Pires, G. S., Tolomeu, H. V., Rodrigues, D. A., Lima, L. M., Fraga, C. A. M., & Pinheiro, P. D. S. M. (2025) · Pharmaceuticals · doi:10.3390/ph18040577 · Cited by 32
A steered molecular dynamics mediated hit discovery for histone deacetylases
Kalyaanamoorthy, S., & Chen, Y. P. (2013) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp53511h · Cited by 32
Histone Deacetylase 8: Characterization of Physiological Divalent Metal Catalysis
Nechay, M. R., Gallup, N. M., Morgenstern, A., Smith, Q. A., Eberhart, M. E., & Alexandrova, A. N. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b00997 · Cited by 32
Madsen, A. S., & Olsen, C. A. (2016) · MedChemComm · doi:10.1039/c5md00451a · Cited by 32
Meinke, P. T., Colletti, S. L., Ayer, M. B., Darkin‐Rattray, S. J., Myers, R. W., Schmatz, D. M., Wyvratt, M. J., & Fisher, M. H. (2000) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)01364-2 · Cited by 32
Li, X., Zhou, Q., Hanus, J., Anderson, C. A., Zhang, H., Dellinger, M. T., Brekken, R. A., & Wang, S. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300445a · Cited by 32
Oxidation of Peptides by Methyl(trifluoromethyl)dioxirane: The Protecting Group Matters
Rella, M. R., & Williard, P. G. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo061910n · Cited by 32
Chelate Effect in Cyclodextrin Dimers: A Computational (MD, MM/PBSA, and MM/GBSA) Study
Beà, I., Gotsev, M. G., Ivanov, P. M., Jaime, C., & Kollman, P. A. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo052469o · Cited by 32
[32] Crystallographic analyses of hyperthermophilic proteins
Rees, D. C. (2001) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(01)34484-1 · Cited by 32
Differentiation induction as a treatment for hematologic malignancies
Miller, W. H., & Waxman, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205328 · Cited by 31
Tng, J., Lim, J., Wu, K., Lucke, A. J., Xu, W., Reid, R. C., & Fairlie, D. P. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00230 · Cited by 31
McGivern, T. J. P., Slator, C., Kellett, A., & Marmion, C. J. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00652 · Cited by 31
Schuetze, K. B., Stratton, M. S., Blakeslee, W. W., Wempe, M. F., Wagner, F. F., Holson, E. B., Kuo, Y., Andrews, A. J., Gilbert, T. M., Hooker, J. M., et al. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.237701 · Cited by 31
Oger, F., Lecorgne, A., Sala, E., Nardese, V., Demay, F., Chevance, S., Desravines, D. C., Aleksandrova, N., Guével, R. L., Lorenzi, S., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901561u · Cited by 31
Mai, A., Perrone, A., Nebbioso, A., Rotili, D., Valente, S., Tardugno, M., Massa, S., Bellis, F. D., & Altucci, L. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.03.055 · Cited by 31
DNA methylation and the core pluripotency network
Shanak, S., & Helms, V. (2020) · Developmental Biology · doi:10.1016/j.ydbio.2020.06.001 · Cited by 31
Reversible histone deacetylase activity catalyzes lysine acylation
Tsusaka, T., Najar, M. A., Schwarz, B. H., Bohrnsen, E., Osés-Prieto, J. A., Neudorf, H., Lee, C., Little, J. P., Burlingame, A. L., Bosio, C. M., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01869-5 · Cited by 31
P300/CBP Regulates HIF-1–Dependent Sympathetic Activation and Hypertension by Intermittent Hypoxia
Wang, N., Su, X., Sams, D., Prabhakar, N. R., & Nanduri, J. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0481oc · Cited by 31
Hake, S. B. (2011) · Wiley eBooks · doi:10.1002/9780470959824.ch3 · Cited by 31
Epigenetic modification enzymes: catalytic mechanisms and inhibitors
Lu, D. (2013) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2013.04.007 · Cited by 31
Song, M.-J., Kim, M.-K., Choi, Y., Yi, M., Kim, J., Park, S., Yong, T., & Kim, H. (2017) · Scientific Reports · doi:10.1038/srep45365 · Cited by 31
Pellicciotta, I., Cortez‐Gonzalez, X., Šášik, R., Reiter, Y., Hardiman, G., Langlade‐Demoyen, P., & Zanetti, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1014 · Cited by 31
Wang, H., Lim, Z., Zhou, Y. F., Ng, M., Lu, T., Lee, K. C. L., Sangthongpitag, K., Goh, K. C., Wang, X., Wu, X., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.041 · Cited by 31
Discovery of novel dual c-Met/HDAC inhibitors as a promising strategy for cancer therapy
Hu, H., Chen, F., Dong, Y., Liu, Y., & Gong, P. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103970 · Cited by 31
Ahmed, M., Jinks, N., Babaei‐Jadidi, R., Kashfi, H., Castellanos‐Uribe, M., May, S. T., Mukherjee, A., & Nateri, A. S. (2019) · Cancers · doi:10.3390/cancers12010106 · Cited by 31
Platinum(IV) prodrugs multiply targeting genomic DNA, histone deacetylases and PARP-1
Xu, Z., Hu, W., Wang, Z., & Gou, S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.074 · Cited by 31
Wang, H., Yu, N., Song, H., Chen, D., Zou, Y., Deng, W., Lye, P. L., Chang, J. W. W., Ng, M., Blanchard, S., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.041 · Cited by 31
Terracciano, S., Micco, S. D., Bifulco, G., Gallinari, P., Riccio, R., & Bruno, I. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.022 · Cited by 30
Khatun, S., Bhagat, R. P., Amin, S. A., Jha, T., & Gayen, S. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108468 · Cited by 30
A Tale of Chromatin and Transcription in 100 Structures
Cramer, P. (2014) · Cell · doi:10.1016/j.cell.2014.10.047 · Cited by 30
Light and Abscisic Acid Coordinately Regulate Greening of Seedlings
Xu, D., Wu, D., Li, X., Jiang, Y., Tian, T., Chen, Q., Ma, L., Wang, H., Deng, X. W., & Li, G. (2020) · PLANT PHYSIOLOGY · doi:10.1104/pp.20.00503 · Cited by 30
Role of Histone Deacetylase Complexes in the Regulation of Chromatin Metabolism
Kuzmichev, A., & Reinberg, D. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-10595-5_2 · Cited by 30
Samuni, Y., Flores‐Santana, W., Krishna, M. C., Mitchell, J. B., & Wink, D. A. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.011 · Cited by 30
The microtubule-targeting agent T0070907 induces proteasomal degradation of tubulin
Harris, G., & Schaefer, K. L. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.009 · Cited by 30
Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
Pchejetski, D., Alfraidi, A., Sacco, K. A., Alshaker, H. A., Muhammad, A., & Monzon, L. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-2064-5 · Cited by 30
An Overview of Naturally Occurring Histone Deacetylase Inhibitors
Kim, B., & Hong, J. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666141208105614 · Cited by 30
Lee, P.-H., Kuo, K.-L., Chu, P.-Y., Liu, E. M., & Lin, J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp359 · Cited by 30
Fernandes, S., Salta, S., & Summavielle, T. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.02.011 · Cited by 30
Delivery systems for vorinostat in cancer treatment: An updated review
Le, V. K. H., Pham, T. P. D., & Truong, D. H. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102334 · Cited by 30
Szabó, O., & Farkas, E. (2011) · Inorganica Chimica Acta · doi:10.1016/j.ica.2011.07.010 · Cited by 30
Curtin, B. F., Pal, N., Gordon, R. K., & Nambiar, M. P. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9084-4 · Cited by 30
Sachs, L. M., Amano, T., Rouse, N., & Shi, Y. (2001) · Developmental Dynamics · doi:10.1002/dvdy.1195 · Cited by 30
Price, S., Bordogna, W., Bull, R. J., Clark, D. E., Crackett, P. H., Dyke, H. J., Gill, M., Harris, N. V., Gorski, J. J., Lloyd, J., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.10.048 · Cited by 30
Metadata
- Authors
- Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Columbia University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Pavletich, Nikola P.
- Venue
- Nature
- Published
- 1999-09
- Volume
- 401
- Issue
- 6749
- Pages
- 188-193
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2135830745
- Cited by
- 1,714
- References
- 28
- Citations by year
- 2026: 39 · 2025: 48 · 2024: 40 · 2023: 55 · 2022: 28 · 2021: 66 · 2020: 62 · 2019: 50 · 2018: 52 · 2017: 70 · 2016: 68 · 2015: 74 · 2014: 67 · 2013: 78 · 2012: 82
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Genentech
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- histone deacetylase, histone deacetylase inhibitors, trichostatin A, vorinostat, Aquifex aeolicus, crystal structure, catalytic site, zinc binding site, hyperthermophilic bacteria, anticancer agents, promyelocytic leukemia
- MeSH terms
- Vorinostat, Amino Acid Sequence, Enzyme Inhibitors, Escherichia coli, Histone Deacetylases, Humans, Hydroxamic Acids, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Recombinant Fusion Proteins, Zinc, Gram-Negative Aerobic Rods and Cocci, Sequence Homology, Amino Acid, Crystallography, X-Ray, Catalytic Domain, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.